PE-Labeled CEACAM-5/CD66e Fc&Avi Tag Protein: An Innovative Tool for Illuminating Precision Diagnosis and Treatment of Epithelial-Derived Tumors
PE-Labeled CEACAM-5/CD66e Fc&Avi Tag Protein is a high-performance fluorescently labeled fusion protein that plays a significant role in the research and therapeutic development of various epithelial-derived tumors, including colorectal cancer, gastric cancer, and lung cancer.
- Recent Advances
- Product Information
PE-Labeled CEACAM-5/CD66e Fc&Avi Tag protein is a high-performance fluorescently labeled fusion protein that plays a pivotal role in the research and therapeutic development of various epithelial-derived tumors, including colorectal cancer, gastric cancer, and lung cancer. This article provides an in-depth analysis of the molecular structure and unique advantages of this protein, as well as a detailed explanation of its significant application value in tumor diagnosis, targeted therapy, and immunotherapy.
I. Molecular Structure Analysis: What is PE-Labeled CEACAM-5/CD66e Fc&Avi Tag Protein?
This is an advanced biological probe that integrates targeting specificity, detection sensitivity, and application flexibility, composed of four meticulously designed core elements:
- CEACAM-5/CD66e Targeting Domain
- Biological Nature: A member of the carcinoembryonic antigen family, a cell surface glycoprotein
- Expression Characteristics:
- Normal Tissues: Low expression in epithelial cells of the gastrointestinal, respiratory, and urinary tracts
- Tumor Tissues: Aberrantly high expression in various epithelial-derived malignancies
- Pathological Significance: A key regulator promoting tumor cell proliferation, invasion, and metastasis
- Fc Chimera Domain
- Engineering Advantage: Genetic fusion of human IgG Fc fragment with the extracellular domain of CEACAM-5
- Functional Features:
- Stable Dimerization: Maintains the natural conformation and biological function of CEACAM-5
- Efficient Purification: Protein A/G affinity chromatography ensures high-purity preparation
- Signal Amplification: Supports secondary antibody-mediated detection signal enhancement
- Avi Tag Labeling System
- Technical Characteristics: A 15-amino acid biotinylation tag
- Unique Advantages:
- Precise Labeling: Site-specific biotinylation catalyzed by BirA enzyme
- Ultra-High Affinity: Irreversible binding to streptavidin
- Application Diversity: Supports various detection platforms and immobilization needs
- PE Fluorescent Reporter System
- Optical Properties: Phycoerythrin, with a large Stokes shift
- Performance Advantages:
- Ultra-High Brightness: Each PE molecule carries multiple fluorescent chromophores
- Exceptional Sensitivity: Ideal for detecting low-abundance antigens
- Multicolor Compatibility: Easily paired with other fluorescent dyes
II. Technical Advantages and Application Scenarios
Core Technical Advantages
Ultra-Sensitive Detection: PE provides an exceptional signal-to-noise ratio, significantly lowering the detection limit
High-Specificity Binding: Maintains the complete biological function and binding properties of CEACAM-5
Application Flexibility: Supports multi-scenario applications from basic research to clinical translation
Major Application Directions
- High-Sensitivity Flow Cytometry
- Precise quantification of CEACAM-5 expression on tumor cell surfaces
- Identification and sorting of circulating tumor cells
- Dynamic monitoring of target expression before and after treatment
- Immunotherapy Product Quality Control
- Validation of CAR-T cell surface receptor expression
- Assessment of antibody drug binding activity
- Consistency testing between batches of therapeutic products
- Drug Screening and Optimization
- Rapid determination of candidate antibody affinity
- Competitive binding analysis
- Epitope identification and characterization
- Advanced Imaging Research
- Spatial localization of CEACAM-5 in tissue sections
- Study of tumor heterogeneity
- Tracking of therapeutic drug distribution in vivo
III. Disease Association: Key Areas in the Diagnosis and Treatment of Epithelial-Derived Tumors
1. Colorectal Cancer (Core Application Area)
Diagnostic Value
Serum Biomarker: CEACAM-5 is an important serum tumor marker for colorectal cancer
Prognostic Assessment: Expression levels are significantly correlated with disease stage and prognosis
Recurrence Monitoring: Postoperative serum level monitoring predicts recurrence risk
Therapeutic Applications
Targeted Drug Development:
Target validation for antibody-drug conjugates
Evaluation of binding properties for bispecific antibodies
Treatment Monitoring:
Early prediction of treatment response
Study of resistance mechanisms
2. Gastric Cancer and Esophageal Cancer
Clinical Significance
Diagnostic Value: Aids in the diagnosis and staging of gastric cancer
Therapeutic Target: Multiple CEACAM-5-targeted therapies are in clinical research
Prognostic Indicator: Expression levels correlate with lymph node metastasis and survival rates
Research Progress
Development of Novel Therapies: Research on specific CAR-T cell therapies
Combination Therapy: Exploration of synergistic effects with traditional chemotherapy
Diagnostic Innovation: CEACAM-5-based liquid biopsy technologies
3. Non-Small Cell Lung Cancer
Expression Characteristics
Tissue Distribution: High expression in lung adenocarcinoma
Clinical Value:
Differential diagnostic indicator
Prognostic factor
Exploration of therapeutic targets
Therapeutic Exploration
Targeted Therapy: Development of specific antibody drugs
Immunotherapy: Research on CAR-T cell therapies
Diagnostic Imaging: Development of radiolabeled probes
4. Breast Cancer and Other Tumors
Breast Cancer: Higher expression in triple-negative breast cancer
Pancreatic Cancer: Potential diagnostic and therapeutic target
Thyroid Cancer: Exploratory targeted therapy research
IV. Cutting-Edge Progress and Future Prospects
Current Research Hotspots
- Development of Novel Immunotherapies
- Optimization of next-generation CAR-T cells
- Development of TCR-mimicking antibodies
- Design of bispecific adapters
- Exploration of Theranostics
- Targeting-diagnosis integrated probes
- Early prediction biomarkers for treatment response
- Development of personalized treatment strategies
- Research on Resistance Mechanisms
- Mechanisms of resistance to targeted therapies
- Optimization of combination therapy strategies
- Discovery of biomarkers
Technological Development Trends
- Integration of Multi-Omics
- Single-cell level analysis of CEACAM-5 expression
- Spatial transcriptome correlation studies
- Proteomic feature analysis
- Acceleration of Clinical Translation
- Development of companion diagnostics
- New methods for treatment monitoring
- Establishment of prognostic prediction models
- Expansion of Innovative Applications
- Novel drug delivery systems
- Development of molecular imaging probes
- Study of microenvironment regulation
Summary
The core value of PE-Labeled CEACAM-5/CD66e Fc&Avi Tag protein is reflected in:
- Research Foundation
- Provides a key tool for the biological study of CEACAM-5
- A standardized platform for targeted therapy development
- Diagnostic Innovation
- Promotes CEACAM-5-based precision diagnostics
- An important support for liquid biopsy technologies
- Therapeutic Breakthrough
- Accelerates the development of novel targeted and immunotherapies
- A reliable guarantee for the quality control of therapeutic products
- Translational Bridge
- Connects basic research with clinical applications
- Drives the development of personalized medicine
With the deepening development of precision medicine in oncology, this high-performance protein tool will undoubtedly play an increasingly important role in the research and treatment of epithelial-derived tumors such as colorectal cancer, gastric cancer, and lung cancer, offering new hope for improving patient prognosis.












